首页 › 基金 › Empyrean Capital Partners, LP › ANIP
Empyrean Capital Partners, LP 对 ANIP 的持仓历史
ANI PHARMACEUTICALS INC COM · 医疗保健
Empyrean Capital Partners, LP 在 Q2 2026 的 13F 申报中披露持有 ANIP(ANI PHARMACEUTICALS INC COM)23,000,000 股,市值约 US$29.7M,约占其申报组合的 0.98%,在其申报持仓中市值排名第 32 位。 Empyrean Capital Partners, LP 最近 4 个申报季度中有 4 个季度披露了 ANIP 持仓,最早可追溯至 Q3 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Empyrean Capital Partners, LP 对 ANIP 的持仓演变
Empyrean Capital Partners, LP 于 Q3 2025 首次披露 ANIP 持仓:23,000,000 股(约 US$32.3M)。 在 4 次申报中,Empyrean Capital Partners, LP 1 次增持、2 次减持、0 次保持不变。 最近一期申报(Q2 2026)显示持股 23,000,000 股、市值约 US$29.7M,环比减持 -500,000 股。。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 23.00M | $32.30M | 新进 |
| Q4 2025 | 21.00M | $26.49M | 减持 |
| Q1 2026 | 23.50M | $29.09M | 增持 |
| Q2 2026 | 23.00M | $29.75M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 ANIP 与 13F 数据
ANIP(ANI PHARMACEUTICALS INC COM)属于医疗保健行业。我们追踪的基金中还有 48 只申报持有 ANIP,申报仓位最大的包括:Soleus Capital Management, L.P. (US$71.8M), TANG CAPITAL MANAGEMENT LLC (US$58.6M), Global Alpha Capital Management Ltd. (US$46.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 ANIP 的基金
- Soleus Capital Management, L.P. 867.76K 股 · $71.83M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 707.50K 股 · $58.57M · Q2 2026
- Global Alpha Capital Management Ltd. 558.00K 股 · $46.19M · Q2 2026
- Ranger Investment Management, L.P. 343.15K 股 · $28.41M · Q2 2026
- HBK INVESTMENTS L P 20.15M 股 · $26.12M · Q2 2026
- Ikarian Capital, LLC 272.08K 股 · $22.52M · Q2 2026
- Jones Hill Capital LP 233.81K 股 · $19.35M · Q2 2026
- Penn Capital Management Company, LLC 207.36K 股 · $17.18M · Q2 2026
- BOUSSARD & GAVAUDAN GESTION SAS 13.00K 股 · $17.07M · Q2 2026
- Parkman Healthcare Partners LLC 202.91K 股 · $16.80M · Q2 2026
- Boussard & Gavaudan Investment Management LLP 13.35K 股 · $16.46M · Q1 2026
- ABSOLUTE INVESTMENT ADVISERS, LLC 11.72M 股 · $15.17M · Q2 2026
更多关于 Empyrean Capital Partners, LP
常见问题
How long has Empyrean Capital Partners, LP held ANIP?
Empyrean Capital Partners, LP has disclosed ANIP holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is Empyrean Capital Partners, LP's current position in ANIP?
As of Q2 2026, Empyrean Capital Partners, LP holds 23.00M shares of ANIP (ANI PHARMACEUTICALS INC COM), valued at $29.75M, representing 0.98% of its reported portfolio and ranking #32.
Has Empyrean Capital Partners, LP been buying or selling ANIP?
In the latest 13F filing (Q2 2026), Empyrean Capital Partners, LP reduced its position in ANIP.
Which other funds hold ANIP?
Other major institutional holders of ANIP include Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, Global Alpha Capital Management Ltd., among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.